Table 4.
POX | Clinical evaluation | POX + clinical evaluation | ||||
---|---|---|---|---|---|---|
≤35 weeks | >35 weeks | ≤35 weeks | >35 weeks | ≤35 weeks | >35 weeks | |
True positives | 6 | 10 | 3 | 9 | 7 | 12 |
False negatives | 1 | 2 | 4 | 3 | 0 | 0 |
False positives | 1384 | 908 | 483 | 468 | 1454 | 1012 |
True negatives | 928 | 889 | 1829 | 1329 | 858 | 785 |
False‐positive rate (%) | 59.9 | 50.5 | 20.9 | 26.0 | 62.9 | 56.3 |
Sensitivity (%) |
85.7 (48.7, 97.4) |
83.3 (55.2, 95.3) |
42.9 (15.8, 75.0) |
75.0 (46.8, 91.1) |
100 (64.6, 100) |
100 (75.8, 100) |
Specificity (%) |
40.1 (38.2, 42.2) |
49.5 (47.2, 51.8) |
79.1 (77.4, 80.7) |
74.0 (71.9, 75.9) |
37.1 (35.2, 39.1) |
43.7 (41.4, 46.0) |
Data: number or percentage (95% CI).